A Comparative Study to Evaluate the Efficacy of Individualized Homoeopathic Medicine versus Calcarea Phosphoricum 12x in Postmenopausal Women with Osteoporosis using T-Score
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
研究概览
简要总结
Osteoporosis is a systemic skeletal disorder characterized by reduced bone strength and deterioration of bone microarchitecture, leading to an increased risk of fractures. Postmenopausal women are particularly vulnerable due to estrogen deficiency, which accelerates bone resorption. Globally, osteoporosis affects a significant proportion of the population, with higher prevalence in women and notably high rates reported in developing countries, including India. In Indian postmenopausal women, the prevalence shows wide regional variation, highlighting the magnitude of the public health burden.
The T-score obtained from DEXA scanning is the gold standard for diagnosing and monitoring osteoporosis, providing a reliable and objective measure of bone mineral density. In homoeopathic practice, both biochemic remedies and individualized constitutional treatment are used in managing osteoporosis. Calcarea Phosphoricum 12X is a well-established biochemic remedy known to support bone metabolism, calcium assimilation, and bone healing, while individualized homoeopathic medicines aim to address the patient holistically.
This study is designed to evaluate and compare the efficacy of individualized homoeopathic medicines and Calcarea Phosphoricum 12X in postmenopausal women with osteoporosis, using T-score as an outcome measure over a 6-month period. Additionally, it seeks to identify commonly indicated individualized homoeopathic remedies used in the management of osteoporosis over an 18-month duration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 45.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- Female
入选标准
- •Confirmed diagnosis of osteoporosis done with Bone Mineral Density Test BMD Test 2) Age group between 45 to 60 years 3) Patients who are willing to participate & give written informed consent.
排除标准
- •Patients having fractures 2) Patients of severe osteoporosis T score of minus two points five with fracture 3) Patients with comorbidities 4) Other major illness such as HIV/AIDS, TB, cardiac condition, renal condition.
研究者
Dr Aashish Rana
Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University
